DavidNeelyTaylorMD

PubMed

• Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.
  Taylor, D. N., Treanor, J. J., Sheldon, E. A., Johnson, C., Umlauf, S., Song, L., Kavita, U., Liu, G., Tussey, L., Ozer, K., Hofstaetter, T., Shaw, A.> ;Vaccine. 2012 Aug 24
• Comparative evaluation of the antibody in lymphocyte supernatant (ALS) and enzyme-linked immunospot (ELISPOT) assays for measuring mucosal immune responses to Shigella...
  Feller, A.J., McKenzie, R., Taylor, D.N., Woods, C.C., Grahek, S.L., Islam, D., Venkatesan, M.M., Hale, T.L., Bourgeois, A.L.> ;Vaccine. 2011 Nov 3
• Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.
  Leaf, D.E., Leaf, D.E.> ;Vaccine. 2011 Jul 18
• Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, S...
  > ;Vaccine. 2011 Jul 12
• 14 citations
  Prevention of Bone Marrow Cell Apoptosis and Regulation of Hematopoiesis by Type I IFNs during Systemic Responses to Pneumocystis Lung Infection
  David L. Taylor, Michelle Wilkison, Jovanka M. Voyich, Nicole Meissner> ;Journal of Immunology. 2011 May 15
• Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico.
  Koo, H.L., Ajami, N.J., Jiang, Z., Neill, F.H., Atmar, R.L., Ericsson, C.D., Okhuysen, P.C., Taylor, D.N., Bourgeois, A.L., Steffen, R., DuPont, H.L.> ;J Clin Microbiol. 2010 May
• Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin.
  Talbot, H.K., Rock, M.T., Johnson, C., Tussey, L., Kavita, U., Shanker, A., Shaw, A.R., Taylor, D.N.> ;PLoS One. 2010
• Systemic pharmacokinetics of rifaximin in volunteers with shigellosis.
  Taylor, D.N., McKenzie, R., Durbin, A., Carpenter, C., Haake, R., Bourgeois, A.L.> ;Antimicrob Agents Chemother. 2008 Mar
• Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
  Dupont, H.L., Jiang, Z., Belkind-Gerson, J., Okhuysen, P.C., Ericsson, C.D., Ke, S., Huang, D.B., Dupont, M.W., Adachi, J.A., De La Cabada, F.J., Taylor, D.N., Jaini, ...> ;Clin Gastroenterol Hepatol. 2007 Apr
• Spinal synovial cysts and intersegmental instability: a chiropractic case.
  Taylor, D.N.> ;J Manipulative Physiol Ther. 2007 Feb
• A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
  Taylor, D.N., Bourgeois, A.L., Ericsson, C.D., Steffen, R., Jiang, Z., Halpern, J., Haake, R., Dupont, H.L.> ;Am J Trop Med Hyg. 2006 Jun
• Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge.
  Taylor, D.N., McKenzie, R., Durbin, A., Carpenter, C., Atzinger, C.B., Haake, R., Bourgeois, A.L.> ;Clin Infect Dis. 2006 May 1
• Poorly absorbed antibiotics for the treatment of traveler's diarrhea.
  Taylor, D.N.> ;Clin Infect Dis. 2005 Dec 1
• Human caliciviruses as a cause of severe gastroenteritis in Peruvian children.
  Parashar, U.D., Li, J., Cama, R., DeZalia, M., Monroe, S.S., Taylor, D.N., Figueroa, D., Gilman, R.H., Glass, R.I.> ;J Infect Dis. 2004 Sep 15
• Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American vo...
  Katz, D.E., Coster, T.S., Wolf, M.K., Trespalacios, F.C., Cohen, D., Robins, G., Hartman, A.B., Venkatesan, M.M., Taylor, D.N., Hale, T.L.> ;Infect Immun. 2004 Feb
• Campylobacter transmission in a Peruvian shantytown: a longitudinal study using strain typing of campylobacter isolates from chickens and humans in household clusters.
  Oberhelman, R.A., Gilman, R.H., Sheen, P., Cordova, J., Taylor, D.N., Zimic, M., Meza, R., Perez, J., LeBron, C., Cabrera, L., Rodgers, F.G., Woodward, D.L., Price, L.J.> ;J Infect Dis. 2003 Jan 15
• Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults.
  Kotloff, K.L., Taylor, D.N., Sztein, M.B., Wasserman, S.S., Losonsky, G.A., Nataro, J.P., Venkatesan, M., Hartman, A., Picking, W.D., Katz, D.E., Campbell, J.D., Levin...> ;Infect Immun. 2002 Apr
• 58 citations
  Randomized, Controlled Human Challenge Study of the Safety, Immunogenicity, and Protective Efficacy of a Single Dose of Peru-15, a Live Attenuated Oral Cholera Vaccine
  Mitchell B. Cohen, Ralph A. Giannella, Judy Bean, David N. Taylor, Susan Parker, Amy Hoeper, Stephen Wowk, Jennifer Hawkins, Sims K. Kochi, Gilbert M. Schiff, Kevin P....> ;Infection and Immunity. 2002 Apr 1
• Effects of nutritional status on diarrhea in Peruvian children.
  Checkley, W., Gilman, R.H., Black, R.E., Lescano, A.G., Cabrera, L., Taylor, D.N., Moulton, L.H.> ;J Pediatr. 2002 Feb
• Join now to see all